End Diagnostic Overshadowing

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-89
SponsorRush University Medical Center

About this trial

The goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholders. Through this work, we will identify and address mechanisms that contribute to diagnostic overshadowing and diagnostic errors among people with disabilities. The main questions to answer are whether knowledge about diagnostic errors and confidence will improve with health care providers and professionals involved in diagnostic provesses, whether developed algorithms to identify patients at risk of diagnpstic error will be used, whether there will be change in time to diagnostic evaluation for PWD from the specified 5 population groups and with the specified diagnoses prone to error, and whether changes in usage of CPT Evaluation and Management codes will occur.

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients under age 3 or over age 89.

Patients with secondary diagnosis of dementia as the population is already known to be at increased risk of diagnostic error

Trial design

Treatments tested in this trial

  • Electonic health record prompts with education
  • Standard of care

Treatment groups

120,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Rush University Medical Center

Lead sponsor

St. John Fisher College

Collaborator

University of Minnesota

Collaborator